Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thromboinflammation and hemostatic activation drive early mortality risk in pulmonary embolism.

Research and practice in thrombosis and haemostasis·2026
Same author

Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin.

Cancers·2026
Same author

A Comparative Study of Porcine and Ovine Derived Defibrotide: Coagulation Profiles, Molecular Characteristics, and DNA Content.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

Circulating Exosomal MicroRNAs as Potential Biomarkers for Pulmonary Embolism.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

Multifactorial thrombotic risk in Evans syndrome: a case report and review of the literature.

Thrombosis journal·2026
Same author

Venous thromboembolism in patients with multiple myeloma treated with B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy: A systematic review.

British journal of haematology·2026
Same journal

A Brief Overview of Colitis Cystica Profunda and Potential Animal Models.

Journal of the American Association for Laboratory Animal Science : JAALAS·2026
Same journal

Collaboration between Human and Veterinary Research and Medical Experts Could Provide a Balanced Discussion on the Ethics of Using Animals in Research.

Journal of the American Association for Laboratory Animal Science : JAALAS·2026
Same journal

Analysis of IVC Microenvironments During an Extended Cage-Change Interval in Rats (Rattus norvegicus).

Journal of the American Association for Laboratory Animal Science : JAALAS·2026
Same journal

Letter to the Editor: Contemporary Concerns Regarding Laboratory Animal Feed.

Journal of the American Association for Laboratory Animal Science : JAALAS·2026
Same journal

Machine Learning in Nonhuman Primate Models of Infectious Diseases: Current Applications and Future Perspectives.

Journal of the American Association for Laboratory Animal Science : JAALAS·2026
Same journal

Performance Validated 8-Week Sanitation Interval for Mouse (Mus musculus) Wire-Bar Lids: ATP and CFU Outcomes.

Journal of the American Association for Laboratory Animal Science : JAALAS·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Coagulation profiling of random-source cats.

Elizabeth McGeehan1, Karen Wielgus, Lee Cera

  • 1Department of Comparative Medicine, Loyola University Medical Center, Maywood, Illinois, USA. emcgeehan@lumc.edu

Journal of the American Association for Laboratory Animal Science : JAALAS
|February 4, 2010
PubMed
Summary
This summary is machine-generated.

Class B vendor cats show significant variations in coagulation and antiprotease activities, potentially impacting their suitability for cardiovascular research. These findings highlight the need for careful consideration of feline health status in research settings.

More Related Videos

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Related Experiment Videos

Last Updated: Jun 16, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Area of Science:

  • Veterinary Medicine
  • Hematology
  • Comparative Physiology

Background:

  • Class B vendor cats (Felis catus) exhibit variable health statuses.
  • Hemostatic parameters and antiprotease activities can differ significantly between animal populations.
  • Understanding coagulation profiles is crucial for animal research subject selection.

Purpose of the Study:

  • To compare hemostatic parameters and antiprotease activities between Class B vendor cats and healthy control cats.
  • To assess the variability of coagulation factors in Class B vendor cats.
  • To determine the suitability of Class B vendor cats for vascular or cardiovascular research.

Main Methods:

  • Comparison of prothrombin time, partial thromboplastin time, common pathway assay, and thrombin time.
  • Measurement of antiprotease activities: anti-factor Xa (antiXa), anti-factor IIa (antiIIa), heparin cofactor II, and antithrombin.
  • Analysis of plasma samples using standard clotting and chromogenic substrate assays.
  • Statistical analysis including tests for homogeneity of variances and one-way ANOVA.

Main Results:

  • Significant differences were observed between groups for heparin cofactor II and Heptest activity levels.
  • Prothrombin time showed significant variance differences between groups, precluding ANOVA.
  • Class B vendor cats displayed wide variations in coagulation parameters compared to controls.

Conclusions:

  • Class B vendor cats exhibit substantial variability in coagulation and antiprotease activities.
  • The wide variations suggest Class B cats may not be optimal subjects for vascular or cardiovascular research.
  • Initial health status likely contributes to the observed hemostatic parameter variations in vendor cats.